bibliographic resource 1038246 [br/1038246]
https://w3id.org/oc/corpus/br/1038246

is a

• document
• article

title

• Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

publication date

• 2009-01-01

contributor

• https://w3id.org/oc/corpus/ar/3410235
• https://w3id.org/oc/corpus/ar/3410236
• https://w3id.org/oc/corpus/ar/3410237
• https://w3id.org/oc/corpus/ar/3410238
• https://w3id.org/oc/corpus/ar/3410239
• https://w3id.org/oc/corpus/ar/3410240
• https://w3id.org/oc/corpus/ar/3410241
• https://w3id.org/oc/corpus/ar/3410242
• https://w3id.org/oc/corpus/ar/3410243
• https://w3id.org/oc/corpus/ar/3410244

format

• https://w3id.org/oc/corpus/re/480182

identifier

• https://w3id.org/oc/corpus/id/1750555
• https://w3id.org/oc/corpus/id/1750556
• https://w3id.org/oc/corpus/id/1750557

part of

• https://w3id.org/oc/corpus/br/535686